Blood tests that measure the amount of cholesterol and triglycerides in your blood are a routine part of most annual checkups ...
MB-111 is a potential first-in-class, single-dose in vivo CRISPR gene editing therapy for persistent chylomicronemia Oral presentation highlights safe, robust, and durable reduction of apoC-III ...